Highlights of ASH in Asia-Pacific 2026 (Updated with Program)

Highlights of ASH in Asia-Pacific 2026 (Updated with Program)

Highlights of ASH Day 1  (Friday, April 10, 2026)

Time Session
8:00 – 8:45 Registration and Exhibits Open
8:45 – 9:00 Welcome & Introductions
9:00 – 9:30
Changing Paradigms of Treatment Approaches for Acute Myeloid Leukemia
Katherine Tarlok, MD — University of Washington, Seattle
 
9:30 – 10:00
Integrating Approved Immunotherapies into Treatment Approaches for Adult B-Precursor Acute Lymphoblastic Leukemia
Adele K. Fielding, MBBS, PhD — Hull York Medical School, England
10:00 – 10:30 Panel Discussion
10:30 – 11:00 Coffee Break (Exhibit Hall)
11:00 – 11:45
From Bench to Bedside: Innovations in Hemoglobinopathy Treatment
Payal Desai, MD — Wake Forest University, USA
Prantar Chakrabarti, MBBS, MD, DNB, DM — Zoho for Healthcare, India
11:45 – 12:15
Artificial Intelligence and Informatics in Hematology
Barbara Lam, MD — Fred Hutchinson Cancer Center, Seattle
12:15 – 12:45 Panel Discussion
12:45 – 2:00 Lunch in Exhibit Hall (All Attendees)
Lunch with the Experts (Ticketed)
2:00 – 3:15
Tumor Board: Evolving Myeloma Treatment Paradigm
Gin Gin Gan, MD — Universiti Malaya, Kuala Lumpur
Shaji Kumar, MD — Mayo Clinic, Rochester
Hang Quach, MBBS, MD — St Vincent's Hospital, Melbourne
3:15 – 3:45 Coffee Break (Exhibit Hall)
3:45 – 4:15
Clinical Features and Management of Histiocytic Neoplasms in the Era of Targeted Therapies
Gaurav Goyal, MD — University of Alabama, Birmingham
4:15 – 4:45
Novel Insights and Emerging Therapies in Immune-Mediated Cytopenias
Michael A. Cole, MD, DPhil — Johns Hopkins Medicine, Baltimore
4:45 – 5:15 Panel Discussion
5:15 – 5:20 Highlights of ASH Day 1 Closing Remarks

Highlights of ASH Day 2  (Saturday, April 11, 2026)

Time Session
8:00 – 8:45 Registration and Exhibits Open
8:45 – 9:00 Welcome & Introductions
9:00 – 9:30
New Frontiers in Bleeding Disorders
Ross Baker, MBBS — Perth Blood Institute, Perth, Australia
9:30 – 10:00
Hematology Through a Gender Lens: Unique and Underrecognized Challenges
Sarah O'Brien, MD, MSc — Nationwide Children's, Columbus, Ohio
10:00 – 10:30 Panel Discussion
10:30 – 11:00 Coffee Break (Exhibit Hall)
11:00 – 12:15
Turning the Tide: Key Cases and Conundrums in Thrombosis Medicine
Lai Heng Lee, MBBS, MD — Singapore General Hospital, Singapore
Ponlapat Rojnuckarin, MD, PhD — Bumrungrad International Hospital, Bangkok
Jeffrey Weitz, MD — McMaster University, Ontario, Canada
12:15 – 1:30 Lunch in the Exhibit Hall (All Attendees)
Lunch with the Experts (Ticketed)
1:30 – 2:00
Updates in Management of Indolent Lymphoma and Chronic Lymphocytic Leukemia
Jia Ruan, MD, PhD — Weill Cornell Medicine, New York
2:00 – 2:45
Novel Treatment Strategies in Aggressive Lymphoma
Steven Park, MD — Wake Forest University, Winston-Salem
Eric Tse, MBBS, PhD — Hong Kong University, Hong Kong
2:45 – 3:15 Panel Discussion
3:15 – 3:45 Coffee Break (Exhibit Hall)
3:45 – 4:30
New Horizons in Transplantation and Cellular Therapies in Asia and Beyond
Robert Negrin, MD — Stanford University, California
William Hwang, MBBS — National Cancer Centre & Singapore General Hospital
4:30 – 5:00
Practice Changing Advances in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Harry Gill Singh, MBBS — HKU Med, Hong Kong
5:00 – 5:30 Panel Discussion
5:30 Highlights of ASH in Asia-Pacific Closing Remarks

Special Registration Support by Education Fund for HOA-Asia Pacific Meeting, April 2026

MSH EDUCATION FUND CALL FOR APPLICATIONS HOA–ASH ASIA PACIFIC MEETING – REGISTRATION SUPPORT

The Malaysian Society of Haematology (MSH) is pleased to announce a special Education Fund initiative to support member participation in the upcoming Highlights of ASH (HOA–ASH) Asia Pacific Meeting.

In line with the objectives of the MSH Education Fund to promote professional development and knowledge exchange among members, the Society will provide limited financial support specifically for meeting registration.

SCOPE OF SUPPORT

Selected applicants will receive support covering the HOA–ASH meeting registration fee of USD 350.

This initiative covers registration fees only. Travel, accommodation, and other related expenses will not be supported under this scheme.

Successful applicants will be required to:

• complete their own meeting registration 

• submit proof of registration and payment receipt 

• claim reimbursement through the usual MSH Education Fund process

ELIGIBILITY

Applicants must meet the following criteria:

• be a current MSH member in good standing 

• hold either Life Membership or Term Associate Membership 

• intend to attend the HOA–ASH Asia Pacific Meeting

In keeping with the educational objectives of the Education Fund, priority may be given to trainees and early‑career haematologists who are less likely to obtain alternative sponsorship.

APPLICATION PROCESS

Members who wish to apply should complete the standard MSH Education Fund Application Form, which can be downloaded from the MSH website at the following link:

https://haematology.org.my/wp-content/uploads/2024/08/New-230814-Education-Funds-Application-Form.pdf

The completed form should indicate the applicant’s intention to attend the meeting and confirm that alternative sponsorship for registration has not been secured.

If the number of applications exceeds the available slots, the Education Fund Committee will prioritise applicants based on the Society’s usual Education Fund principles, including support for trainees, first‑time applicants, and members who have not recently received Education Fund support.

APPLICATION DEADLINE

Applications must be submitted by midnight, Sunday, 22 March 2026.

Members are encouraged to apply before the end of the stated deadline as late submissions will not be considered.

Successful applicants will be notified after review by the Education Fund Committee.

For further information, please contact the MSH Secretariat.